Deoxyribonuclease activity of polyclonal IgGs: A putative serological marker in patients with spondyloarthritides

Immunologic Research

Volumn 56, Issue 2-3, 2013, Pages 457-464

  Kundzer, Alena V ^a   Volkova, Margarita V ^b   Bogdanos, Dimitrios P ^c   Rödiger, Stefan ^f   Schierack, Peter ^f   Generalov, I ^b   Nevinsky, Georgy A ^d   Roggenbuck, Dirk ^e,f  

^a BELARUSIAN MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Belarus)

^b VITEBSK STATE MEDICAL UNIVERSITY   (Belarus)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^e GA GENERIC ASSAYS GMBH   (Germany)

^f UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Abzyme; Catalytic activity; Deoxyribonuclease activity; Polyclonal IgG; Spondyloarthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CATALYTIC ANTIBODY; DEOXYRIBONUCLEASE; HLA B27 ANTIGEN; IMMUNOGLOBULIN G; METHOTREXATE; MYELIN BASIC PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEIC ACID; POLYCLONAL ANTIBODY; POLYSACCHARIDE; RNA; SALAZOSULFAPYRIDINE; THYROGLOBULIN;

AFFINITY CHROMATOGRAPHY; AGAR GEL ELECTROPHORESIS; ANKYLOSING SPONDYLITIS ENTHESITIS SCORE; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; BATH ANKYLOSING SPONDYLITIS RADIOLOGY INDEX; COMPLEMENTARITY DETERMINING REGION; CONNECTIVE TISSUE; CYTOLYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIATIC ARTHRITIS; PURIFICATION; RANGE OF MOTION; RHEUMATIC DISEASE; SEROLOGY; SPONDYLITIS; SPONDYLOARTHRITIDES; SYNOVITIS; TREATMENT DURATION;

ANTIBODIES, CATALYTIC; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DEOXYRIBONUCLEASES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN G; SEROLOGIC TESTS; SPONDYLARTHROPATHIES;

EID: 84879553576     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8424-9     Document Type: Article

References (65)

1. Nevinsky GA, Buneva VN. Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases. J Cell Mol Med. 2003;7:265-76. (Pubitemid 37372046)
2. Shuster AM, Gololobov GV, Kvashuk OA, Bogomolova AE, Smirnov IV, Gabibov AG. DNA hydrolyzing autoantibodies. Science. 1992;256:665-7.
3. Wootla B, Lacroix-Desmazes S, Warrington AE, Bieber AJ, Kaveri SV, Rodriguez M. Autoantibodies with enzymatic properties in human autoimmune diseases. J Autoimmun. 2011;37:144-50.
4. Pavlovic M, Kats A, Cavallo M, Chen R, Hartmann JX, Shoenfeld Y. Pathogenic and epiphenomenal anti-DNA antibodies in SLE. Autoimmune Dis. 2011;2011:462841.
5. Taguchi H, Planque S, Nishiyama Y, Szabo P, Weksler ME, Friedland RP, Paul S. Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmun Rev. 2008;7:391-7.
6. Kozyr AV, Kolesnikov AV, Aleksandrova ES, Sashchenko LP, Gnuchev NV, Favorov PV, Kotelnikov MA, Iakhnina EI, Astsaturov IA, Prokaeva TB, Alekberova ZS, Suchkov SV, Gabibov AG. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol. 1998;75:45-61. (Pubitemid 29168618)
7. Baranovsky AG, Matushin VG, Vlassov AV, Zabara VG, Naumov VA, Giege R, Buneva VN, Nevinsky GA. DNA- and RNA-hydrolyzing antibodies from the blood of patients with various forms of viral hepatitis. Biochemistry (Mosc). 1997;62:1358-66. (Pubitemid 127595488)
8. Baranovskii AG, Kanyshkova TG, Mogelnitskii AS, Naumov VA, Buneva VN, Gusev EI, Boiko AN, Zargarova TA, Favorova OO, Nevinsky GA. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Mosc). 1998;63:1239-48. (Pubitemid 128585494)
9. Kalaga R, Li L, O'Dell JR, Paul S. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J Immunol. 1995;155:2695-702.
10. Planque S, Nishiyama Y, Taguchi H, Salas M, Hanson C, Paul S. Catalytic antibodies to HIV: physiological role and potential clinical utility. Autoimmun Rev. 2008;7:473-9.
11. Gabibov AG, Ponomarenko NA, Tretyak EB, Paltsev MA, Suchkov SV. Catalytic autoantibodies in clinical autoimmunity and modern medicine. Autoimmun Rev. 2006;5:324-30. (Pubitemid 43868200)
12. Nevinsky GA, Kanyshkova TG, Buneva VN. Natural catalytic antibodies (abzymes) in normalcy and pathology. Biochemistry (Mosc). 2000;65:1245-55.
13. Ponomarenko NA, Durova OM, Vorobiev II, Belogurov AA Jr, Kurkova IN, Petrenko AG, Telegin GB, Suchkov SV, Kiselev SL, Lagarkova MA, Govorun VM, Serebryakova MV, Avalle B, Tornatore P, Karavanov A, Morse HC III, Thomas D, Friboulet A, Gabibov AG. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci USA. 2006;103:281-6. (Pubitemid 43122392)
14. Breusov AA, Gal'vita AV, Benzo ES, Baranovskii AG, Prints AV, Naumov VA, Buneva VN, Nevinsky GA. Comparison of the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto's thyroiditis and nontoxic nodal goiter. Russ J Immunol. 2001;6:17-28.
15. Andrievskaya OA, Buneva VN, Baranovskii AG, Gal'vita AV, Benzo ES, Naumov VA, Nevinsky GA. Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. Immunol Lett. 2002;81:191-8. (Pubitemid 34310224)
16. Bayry J, Lacroix-Desmazes S, Pashov A, Stahl D, Hoebeke J, Kazatchkine MD, Kaveri SV. Autoantibodies to factor VIII with catalytic activity. Autoimmun Rev. 2003;2:30-5. (Pubitemid 37443869)
17. Kundzer EV, Generalov II, Volkova MV. DNAse serum and catalytic IgG activity in patients with spondyloarthropathies. Ann Rheum Dis. 2011;70(suppl 13):336.
18. Kundzer EV, Volkova MV. DNAse serum and IgG activity in patients with axial and peripheral spondyloarthropathies. Ann Rheum Dis. 2012;71(suppl 13):557.
19. Shuster AM, Gololobov GV, Kvashuk OA, Bogomolova AE, Smirnov IV, Gabibov AG. Interaction of catalytically active antibodies with DNA. Dokl Akad Nauk SSSR. 1991;319:1504-7.
20. Shuster AM, Gololobov GV, Kvashuk OA, Gabibov AG. Dna-specific catalytic antibodies in human blood sera. Dokl Akad Nauk SSSR. 1991;318:1262-4.
21. Parkhomenko TA, Odintsova ES, Buneva VN, Kunder EV, Zhyltsov IV, Senkovich SA, Generalov II, Nevinsky GA. DNA-hydrolysing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections. J Cell Mol Med. 2009;13:2875-87.
22. Gololobov GV, Bogomolova AE, Iadav RP, Ermolaeva MV, Belostotskaia KM, Prokaeva TB, Shuster AM, Gabibov AG. Isolation and characteristics of catalytic antibodies to DNA in systemic lupus erythematosus. Biokhimiia. 1993;58:313-8.
23. Gabibov AG, Gololobov GV, Makarevich OI, Schourov DV, Chernova EA, Yadav RP. DNA-hydrolyzing autoantibodies. Appl Biochem Biotechnol. 1994;47:293-302.
24. Khitrov AN, Romadanova NB, Ogneva EA, Naumova TE, Alekberova ZS, Vorob'ev II, Gabibov AG, Ponomarenko NA, Suchkov SV. DNA-abzymes in rheumatoid arthritis: pathogenetic and clinical significance. Ter Arkh. 2005;77:75-80. (Pubitemid 43074619)
25. Buneva VN, Kudryavtseva AN, Gal'vita AV, Dubrovskaya VV, Khokhlova OV, Kalinina IA, Galenok VA, Nevinsky GA. Dynamics of antibody nuclease activity in blood of women during pregnancy and lactation. Biochemistry (Mosc). 2003;68:890-900.
26. Kanyshkova TG, Semenov DV, Khlimankov DY, Buneva VN, Nevinsky GA. DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers. FEBS Lett. 1997;416:23-6. (Pubitemid 27470793)
27. Li L, Paul S, Tyutyulkova S, Kazatchkine MD, Kaveri S. Catalytic activity of anti-thyroglobulin antibodies. J Immunol. 1995;154:3328-32.
28. Vlassov A, Florentz C, Helm M, Naumov V, Buneva V, Nevinsky G, Giege R. Characterization and selectivity of catalytic antibodies from human serum with RNase activity. Nucleic Acids Res. 1998;26:5243-50. (Pubitemid 28542720)
29. Gabibov AG, Kozyr AV, Kolesnikov AV. Disease association and cytotoxic effects of DNA-hydrolyzing autoantibodies. Chem Immunol. 2000;77:130-56.
30. Gololobov GV, Mikhalap SV, Starov AV, Kolesnikov AF, Gabibov AG. DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. Appl Biochem Biotechnol. 1994;47:305-14.
31. Kozyr AV, Kolesnikov AV, Zelenova NA, Sashchenko LP, Mikhalap SV, Bulina ME, Ignatova AN, Favorov PV, Gabibov AG. Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity. Appl Biochem Biotechnol. 2000;83:255-68.
32. Lee EJ, Jang EJ, Lee E, Yu J, Chung HY, Jang YJ. Cell-penetrating autoantibody induces caspase-mediated apoptosis through catalytic hydrolysis of DNA. Bioorg Med Chem. 2007;15:2016-23. (Pubitemid 46188403)
33. Belogurov AA, Kurkova IN, Misikov VK, Suchkov SV, Telegin GB, Alekhine AI, Goncharov NG, Knorre VD, Gabibov AG, Ponomarenko NA. Substrate specificity of catalytic autoantibodies in neurodegenerative processes. Dokl Biochem Biophys. 2007;413:61-4. (Pubitemid 46726056)
34. Ponomarenko NA, Durova OM, Vorobiev II, Belogurov AA, Telegin GB, Suchkov SV, Misikov VK, Morse HC III, Gabibov AG. Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale. Immunol Lett. 2006;103:45-50. (Pubitemid 43162945)
35. Lacroix-Desmazes S, Wootla B, Dasgupta S, Delignat S, Bayry J, Reinbolt J, Hoebeke J, Saenko E, Kazatchkine MD, Friboulet A, Christophe O, Nagaraja V, Kaveri SV. Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII. J Immunol. 2006;177:1355-63. (Pubitemid 44036643)
36. Wootla B, Mahendra A, Dimitrov JD, Friboulet A, Borel-Derlon A, Rao DN, Uda T, Borg JY, Bayry J, Kaveri SV, Lacroix-Desmazes S. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia. FEBS Lett. 2009;583:2565-72.
37. Wootla B, Rao DN, Friboulet A, Uda T, Lacroix-Desmazes S, Kaveri SV. Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies. Clin Rev Allergy Immunol. 2009;37:97-104.
38. Kolesnikov AV, Kozyr AV, Alexandrova ES, Koralewski F, Demin AV, Titov MI, Avalle B, Tramontano A, Paul S, Thomas D, Gabibov AG, Friboulet A. Enzyme mimicry by the antiidiotypic antibody approach. Proc Natl Acad Sci USA. 2000;97:13526-31.
39. Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev. 2010;9:A325-9.
40. Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology (Oxford). 2002;41:857-68.
41. Mathieu A, Paladini F, Vacca A, Cauli A, Fiorillo MT, Sorrentino R. The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun Rev. 2009;8:420-5.
42. Chatzikyriakidou A, Voulgari PV, Drosos AA. What is the role of HLA-B27 in spondyloarthropathies? Autoimmun Rev. 2011;10:464-8.
43. Hoffman IE, Demetter P, Peeters M, De VM, Mielants H, Veys EM, De KF. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis. 2003;62:455-9. (Pubitemid 36469739)
44. Mundwiler ML, Mei L, Landers CJ, Reveille JD, Targan S, Weisman MH. Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study. Arthr Res Ther. 2009;11:R177.
45. Baerlecken N, Stummvoll GH, Rudwaleit M, Sieper J, Schmidt RE, Witte T. Autoantibodies against class II - associated invariant chain peptide (CLIP) in spondyloarthritis? 8th Autoimmune congress on Autoimmunity. 2012.
46. De RL, Kruithof E, Van DN, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De KF. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondyloarthropathy. Arthritis Rheum. 2003;48:1015-23. (Pubitemid 36418243)
47. Johnson SR, Schentag CT, Gladman DD. Autoantibodies in biological agent naive patients with psoriatic arthritis. Ann Rheum Dis. 2005;64:770-2. (Pubitemid 40559308)
48. Calzavara-Pinton PG, Franceschini F, Manera C, Zane C, Prati E. Incidence of antiperinuclear factor in patients with psoriatic arthritis. Adv Exp Med Biol. 1999;455:215-20. (Pubitemid 32187463)
49. Conrad K, Ittenson A, Reinhold D, Fischer R, Roggenbuck D, Buttner T, Bosselmann HP, Steinbach J, Schossler W. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test. Ann N Y Acad Sci. 2009;1173:180-5.
50. Roggenbuck D, Conrad K, Reinhold D. High sensitive detection of double-stranded DNA antibodies by a modified Crithidia luciliae immunofluorescence test may improve diagnosis of systemic lupus erythematosus. Clin Chim Acta. 2010;411:1837-8.
51. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum. 1991;34:1218-27.
52. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665-73. (Pubitemid 44205029)
53. Braun J, Kingsley G, van der Heijde D, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J Rheumatol. 2000;27:2185-92.
54. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361-8. (Pubitemid 14134775)
55. van de Kerkhof PC. The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion. Br J Dermatol. 1997;137:661-2. (Pubitemid 27469538)
56. Rahman P, Gladman DD, Cook RJ, Zhou Y, Young G, Salonen D. Radiological assessment in psoriatic arthritis. Br J Rheumatol. 1998;37:760-5.
57. MacKay K, Mack C, Brophy S, Calin A. The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum. 1998;41:2263-70. (Pubitemid 29009386)
58. Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, Landewe R, Dougados M, Mielants H, van der Tempel H, van der Heijde D. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum. 2004;51:154-9. (Pubitemid 38468696)
59. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21:2281-5.
60. Conrad K, Roggenbuck D, Reinhold D, Sack U. Autoantibody diagnostics in clinical practice. Autoimmun Rev. 2011;207-211.
61. Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev. 2009;8:543-8.
62. Hiemann R, Buttner T, Krieger T, Roggenbuck D, Sack U, Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev. 2009;9:17-22.
63. Grossmann K, Roggenbuck D, Schroder C, Conrad K, Schierack P, Sack U. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay. Cytom A. 2011;79:118-25.
64. Rodiger S, Schierack P, Bohm A, Nitschke J, Berger I, Frommel U, Schmidt C, Ruhland M, Schimke I, Roggenbuck D, Lehmann W, Schroder C. A highly versatile microscope imaging technology platform for the multiplex real-time detection of biomolecules and autoimmune antibodies. Adv Biochem Eng Biotechnol. 2012 (in press).
65. Willitzki A, Hiemann R, Peters V, Sack U, Schierack P, Rodiger S, Anderer U, Bogdanos DP, Reinhold D, Roggenbuck D. New platform technology for comprehensive serological diagnostics of autoimmune disease. Clin Dev Immunol. 2012;2012:284740. Research